World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: JPRN
Last refreshed on: 17 October 2023
Main ID:  JPRN-UMIN000015832
Date of registration: 05/12/2014
Prospective Registration: Yes
Primary sponsor: Clinical Research Support Center Kyushu
Public title: Study of duodenal juice Analysis of the markers in the duodenal juice to detect early stage pancreatic cancer
Scientific title: Study of duodenal juice Analysis of the markers in the duodenal juice to detect early stage pancreatic cancer - Analysis of the markers in the duodenal juice to detect early stage pancreatic cancer
Date of first enrolment: 2015/05/22
Target sample size: 1200
Recruitment status: Complete: follow-up complete
URL:  https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018045
Study type:  Interventional
Study design:  Single arm Non-randomized  
Phase:  Phase II
Countries of recruitment
Japan
Contacts
Name:     Takao Ohtsuka
Address:  3-1-1, Maidashi, Higashi-Ku, Fukuoka, 812-8582 , Japan Japan
Telephone: 092-631-2920
Email: dj@cres-kyushu.or.jp
Affiliation:  Graduate School of Medical Sciences, Kyushu University Department of Surgery and Oncology
Name:     Masao Tanaka
Address:  1-13-1 Koyocho, Shimonoseki, Yamaguchi, 750-8520, Japan Japan
Telephone: 092-631-2920
Email: dj@cres-kyushu.or.jp
Affiliation:  Shimonoseki City Hospital Graduate School of Medical Sciences, Kyushu University ditector
Key inclusion & exclusion criteria
Inclusion criteria:
Exclusion criteria: 1) They have no drug hypersensitivity. 2) The doctor-in-charge figures them to be suitable for this study.

Age minimum: 50years-old
Age maximum: Not applicable
Gender: Male and Female
Health Condition(s) or Problem(s) studied
Pancreatic cancer
Intervention(s)
At the beginning of the endoscopy, the duodenum is entered within a few minutes and we collect the duodenal juice. The collection of duodenal juice The duodenal juice is collected using PR-130Q catheter and 20ml-syringe. The catheter is removed when the sample reaches more than 0.3ml or the procedure takes more than 5 minutes. The sample is immediately put into 2ml-tube with a protease inhibitor (Roche) and stored at -80degrees.
Primary Outcome(s)
The protein levels in the duodenal juice to detect patients with stage 0/1 pancreatic cancer
Secondary Outcome(s)
The protein levels in the duodenal juice to detect pancreatic cancer and its sensitivity, The protein levels in the duodenal juice to detect pancreatic diseases
Secondary ID(s)
Source(s) of Monetary Support
Olympus Corp
Secondary Sponsor(s)
Ethics review
Status: YES
Approval date:
Contact:
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history